Drug Interactions between Azithromycin Dose Pack and tipiracil / trifluridine
This report displays the potential drug interactions for the following 2 drugs:
- Azithromycin Dose Pack (azithromycin)
- tipiracil/trifluridine
Interactions between your drugs
No interactions were found between Azithromycin Dose Pack and tipiracil / trifluridine. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Azithromycin Dose Pack
A total of 376 drugs are known to interact with Azithromycin Dose Pack.
- Azithromycin dose pack is in the drug class macrolides.
-
Azithromycin dose pack is used to treat the following conditions:
- Babesiosis
- Bacterial Endocarditis Prevention
- Bacterial Infection
- Bartonellosis
- Bronchitis
- Cervicitis
- Chancroid
- Chlamydia Infection
- COPD, Acute
- Cystic Fibrosis
- Gonococcal Infection, Uncomplicated
- Granuloma Inguinale
- Legionella Pneumonia
- Lyme Disease, Erythema Chronicum Migrans
- Middle Ear Infections
- Mycobacterium avium-intracellulare, Prophylaxis
- Mycobacterium avium-intracellulare, Treatment
- Mycoplasma Pneumonia
- Nongonococcal Urethritis
- Pelvic Inflammatory Disease
- Pertussis
- Pertussis Prophylaxis
- Pharyngitis
- Pneumonia
- Sinusitis
- Skin and Structure Infection
- Skin or Soft Tissue Infection
- STD Prophylaxis
- Tonsillitis/Pharyngitis
- Toxoplasmosis
- Typhoid Fever
- Upper Respiratory Tract Infection
tipiracil / trifluridine
A total of 215 drugs are known to interact with tipiracil / trifluridine.
- Tipiracil / trifluridine is in the drug class antineoplastic combinations.
- Tipiracil / trifluridine is used to treat the following conditions:
Drug and food interactions
trifluridine food
Applies to: tipiracil / trifluridine
ADJUST DOSING INTERVAL: Administration of trifluridine-tipiracil with a standardized high-fat, high-calorie meal has been shown to decrease trifluridine peak plasma concentration (Cmax) as well as tipiracil Cmax and systemic exposure (AUC) by approximately 40% compared to administration in a fasting state in patients with cancer given a single 35 mg/m2 dose. No change in trifluridine AUC was observed.
MANAGEMENT: Based on the observed correlation between increases in the Cmax of trifluridine and decreases in neutrophil counts, trifluridine-tipiracil should be taken within one hour after completion of the morning and evening meals.
References (1)
- (2015) "Product Information. Lonsurf (tipiracil-trifluridine)." Taiho Oncology, Inc.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.